The % downregulation of CD62L MFI by IL-15 in NK cells was comparable between SLE patients and controls (21.3 ± 3.3% versus 23.8 ± 4.4%, p = 0.66). The gene discussed is SELL; the disease is systemic lupus erythematosus.